Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus

Kaohsiung Journal of Medical Sciences

Volumn 30, Issue 7, 2014, Pages 350-361

  Xu, Youhua ^a   Lin, Jing ^b   Wang, Shanshan ^a,c   Xiong, Jianfeng ^a   Zhu, Quan ^a  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Diabetes; Estrogen replacement therapy; Meta analysis; Systematic review; Women

Indexed keywords

ESTRADIOL; ESTROGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROGESTERONE; TRIACYLGLYCEROL; GESTAGEN; GLUCOSE BLOOD LEVEL;

ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; DATA EXTRACTION; DIABETES MELLITUS; DIET RESTRICTION; ESTROGEN THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; MEDLINE; META ANALYSIS; METABOLIC REGULATION; POSTMENOPAUSE; RISK FACTOR; SYSTEMATIC REVIEW; BLOOD; BODY MASS; CARBOHYDRATE METABOLISM; DRUG COMBINATION; DRUG EFFECTS; FEMALE; LIPID METABOLISM;

BLOOD GLUCOSE; BODY MASS INDEX; CARBOHYDRATE METABOLISM; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LIPID METABOLISM; POSTMENOPAUSE; PROGESTINS; TRIGLYCERIDES;

EID: 84902360940     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2014.03.002     Document Type: Article

References (55)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 31 Suppl. 1 2008 S55 S60
2. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
3. S. Mayor International Diabetes Federation consensus on prevention of type 2 diabetes Int J Clin Pract 61 2007 1773 1775
4. P.W. Sullivan, E.H. Morrato, V. Ghushchyan, H.R. Wyatt, and J.O. Hill Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002 Diabetes Care 28 2005 1599 1603
5. E.L. Ding, Y. Song, V.S. Malik, and S. Liu Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis JAMA 295 2006 1288 1299
6. S. Kaplan A model of person-environment compatibility Environ Behav 15 1983 311 332
7. N.L. Keating, P.D. Cleary, A.S. Rossi, A.M. Zaslavsky, and J.Z. Ayanian Use of hormone replacement therapy by postmenopausal women in the United States Ann Intern Med 130 1999 545 553
8. D.A. Redelmeier, S.H. Tan, and G.L. Booth The treatment of unrelated disorders in patients with chronic medical diseases N Engl J Med 338 1998 1516 1520
9. J.C. Robinson, A.R. Folsom, A.A. Nabulsi, R. Watson, F.L. Brancati, and J. Cai Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? Diabetes Care 19 1996 480 485
10. R.S. Stafford, D. Saglam, N. Causino, and D. Blumenthal Low rates of hormone replacement in visits to United States primary care physicians Am J Obstet Gynecol 177 1997 381 387
11. M.I. Harris, K.M. Flegal, C.C. Cowie, M.S. Eberhardt, D.E. Goldstein, and R.R. Little et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994 Diabetes Care 21 1998 518 524
12. S.R. Salpeter, J.M. Walsh, T.M. Ormiston, E. Greyber, N.S. Buckley, and E.E. Salpeter Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women Diabetes Obes Metab 8 2006 538 554
13. R.E. Van Pelt, W.S. Gozansky, R.S. Schwartz, and W.M. Kohrt Intravenous estrogens increase insulin clearance and action in postmenopausal women Am J Physiol Endocrinol Metab 285 2003 E311 E317
14. C. González, A. Alonso, N. Alvarez, F. Díaz, M. Martínez, and S. Fernández et al. Role of 17beta-estradiol and/or progesterone on insulin sensitivity in the rat: implications during pregnancy J Endocrinol 166 2000 283 291
15. R. Kimmerle, L. Heinemann, T. Heise, R. Bender, C. Weyer, and S. Hirschberger et al. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women Menopause 6 1999 36 42
16. D.E. Bonds, N. Lasser, L. Qi, R. Brzyski, B. Caan, and G. Heiss et al. The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial Diabetologia 49 2006 459 468
17. K.L. Margolis, D.E. Bonds, R.J. Rodabough, L. Tinker, L.S. Phillips, and C. Allen et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial Diabetologia 47 2004 1175 1187
18. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
19. L.L. Gabal, D. Goodman-Gruen, and E. Barrett-Connor The effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus Am J Public Health 87 1997 443 445
20. J.T. Dubuisson, L.E. Wagenknecht, R.B. D'Agostino Jr., S.M. Haffner, M. Rewers, and M.F. Saad et al. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes Diabetes Care 21 1998 790 796
21. T.B. Monster, W.M. Janssen, P.E. de Jong, and L.T. de Jong-van den Berg Prevention of Renal and Vascular End Stage Disease Study Group. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria Arch Intern Med 161 2001 2000 2005
22. C.J. Crespo, E. Smit, A. Snelling, C.T. Sempos, R.E. Andersen NHANES III Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III) Diabetes Care 25 2002 1675 1680
23. Y. Zhang, B.V. Howard, L.D. Cowan, T.K. Welty, C.F. Schaefer, and R.A. Wild et al. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic American Indian women: the Strong Heart Study J Womens Health (Larchmt) 13 2004 155 163
24. K. Pentti, M.T. Tuppurainen, R. Honkanen, L. Sandini, H. Kröger, and E. Alhava et al. Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study Eur J Endocrinol 160 2009 979 983
25. M. Agarwal, V. Selvan, B.I. Freedman, Y. Liu, and L.E. Wagenknecht The relationship between albuminuria and hormone therapy in postmenopausal women Am J Kidney Dis 45 2005 1019 1025
26. R.E. van Genugten, K.M. Utzschneider, J. Tong, F. Gerchman, S. Zraika, and J. Udayasankar et al. Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes Diabetes 55 2006 3529 3535
27. B. Andersson, L.A. Mattsson, L. Hahn, P. Mårin, L. Lapidus, and G. Holm et al. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 82 1997 638 643
28. W.H. Sutherland, P.J. Manning, S.A. de Jong, A.R. Allum, S.D. Jones, and S.M. Williams Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women Metabolism 50 2001 319 324
29. A.M. Kanaya, D. Herrington, E. Vittinghoff, F. Lin, D. Grady, and V. Bittner et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial Ann Intern Med 138 2003 1 9
30. J. McKenzie, A.J. Jaap, S. Gallacher, A. Kelly, L. Crawford, and I.A. Greer et al. Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? Clin Endocrinol (Oxf) 59 2003 682 689
31. L. Thunell, B. Andersson, M. Glassell, and L.A. Mattsson The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes Maturitas 53 2006 430 438
32. A.F. Kernohan, N. Sattar, T. Hilditch, S.J. Cleland, M. Small, and M.A. Lumsden et al. Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes Clin Endocrinol (Oxf) 66 2007 27 34
33. A.R. Scott, P. Dhindsa, J. Forsyth, and P. Mansell Kliofem Study Collaborative Group. Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes Diabetes Obes Metab 6 2004 16 22
34. S. Lamon-Fava, D.M. Herrington, K.V. Horvath, E.J. Schaefer, and B.F. Asztalos Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status Metabolism 59 2010 1794 1800
35. G.M. Reaven Pathophysiology of insulin resistance in human disease Physiol Rev 75 1995 473 486
36. M. Chen, S.C. Woods, and D. Porte Jr. Effect of cerebral intraventricular insulin on pancreatic insulin secretion in the dog Diabetes 24 1975 910 914
37. E. Barrett-Connor, and M. Laakso Ischaemic heart disease risk in post-menopausal women: effect of estrogen on glucose and insulin levels Arterioesclerosis 10 1990 531 534
38. R.J. Troisi, C.C. Cowie, and M.I. Harris Oral contraceptive use and glucose metabolism in a national sample of women in the United States Am J Obstet Gynecol 183 2000 389 395
39. P.A. Heine, J.A. Taylor, G.A. Iwamoto, D.B. Lubahn, and P.S. Cooke Increased adipose tissue in male and female estrogen receptor-alpha knockout mice Proc Natl Acad Sci USA 97 2000 12729 12734
40. E.P. Smith, J. Boyd, G.R. Frank, H. Takahashi, R.M. Cohen, and B. Specker et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man N Engl J Med 331 1994 1056 1061
41. J.M. Backer, M.G. Myers Jr., S.E. Shoelson, D.J. Chin, X.J. Sun, and M. Miralpeix et al. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation EMBO J 11 1992 3469 3479
42. A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, and V.S. Bales et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 JAMA 289 2003 76 79
43. D.A. Schoeller, and A.C. Buchholz Energetics of obesity and weight control: does diet composition matter? J Am Diet Assoc 105 2005 24 28
44. M.R. Taskinen Diabetic dyslipidaemia: from basic research to clinical practice Diabetologia 46 2003 733 749
45. S.D. Malnick, M. Beergabel, and H. Knobler Non-alcoholic fatty liver: a common manifestation of a metabolic disorder QJM 96 2003 699 709
46. D. Unal, S. Aksak, Z. Halici, O. Sengul, B. Polat, and B. Unal et al. Effects of diabetes mellitus on the rat liver during the postmenopausal period J Mol Histol 42 2011 273 287
47. J. McKenzie, B.M. Fisher, A.J. Jaap, A. Stanley, K. Paterson, and N. Sattar Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial Clin Endocrinol (Oxf) 65 2006 40 44
48. S. Bruno, P. Maisonneuve, P. Castellana, N. Rotmensz, S. Rossi, and M. Maggioni et al. Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial BMJ 330 2005 932
49. Y. Nemoto, K. Toda, M. Ono, K. Fujikawa-Adachi, T. Saibara, and S. Onishi et al. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice J Clin Invest 105 2000 1819 1825
50. J.D. Chow, M.E. Jones, K. Prelle, E.R. Simpson, and W.C. Boon A selective estrogen receptor {alpha} agonist ameliorates hepatic steatosis in the male aromatase knockout mouse J Endocrinol 210 2011 323 334
51. L. Zhu, W.C. Brown, Q. Cai, A. Krust, P. Chambon, and O.P. McGuinness et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance Diabetes 62 2013 424 434
52. E. Løkkegaard, A.T. Pedersen, B.L. Heitmann, Z. Jovanovic, N. Keiding, and Y.A. Hundrup et al. Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study BMJ 326 2003 426
53. R.J. Santen, D.C. Allred, S.P. Ardoin, D.F. Archer, N. Boyd, and G.D. Braunstein et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement J Clin Endocrinol Metab 95 7 Suppl 1 2010 S1 S66
54. R.M. Tamimi, S.E. Hankinson, W.Y. Chen, B. Rosner, and G.A. Colditz Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women Arch Intern Med 166 2006 1483 1489
55. M. Hofling, K. Carlström, G. Svane, E. Azavedo, H. Kloosterboer, and B. Von Schoultz Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels - an association with mammographic density Gynecol Endocrinol 20 2005 110 115